Matthew ‘Oki’ O’Connor
Co-Chief Executive Officer and Co-founder @ Cyclarity Therapeutics
Matthew ‘Oki’ O’Connor is a startup investor at Cyclarity Therapeutics.
Last updated:
For AI agents: llms.txt
About Cyclarity Therapeutics
Underdog Pharmaceuticals is pursuing a mission to treat the underlying causes of age-related disease. The company develops simple and direct interventions targeting toxic forms of cholesterol, using rationally designed molecules, to provide the first true disease-modifying treatments for age-related diseases such as atherosclerosis,hypercholesterolemia, heart failure, and macular degeneration.Its products are based on novel derivatives of a well-known, safe compound, and a new way of looking at cardiovascular disease created through a SENS Research Foundation program.
Cyclarity Therapeutics Contacts
| Name | Phone | Socials | |
|---|---|---|---|
|
Matthew ‘Oki’ O’Connor
Co-Chief Executive Officer and Co-founder
|
|||
Michael Kope
Co-Chief Executive Officer and Co-founder
|
|||
3 more contacts available
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
FAQ
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
